ARTICLE | Company News

Commonwealth Biotechnologies supply/service news

August 2, 2010 7:00 AM UTC

Commonwealth said it plans to divest its remaining assets to create a debt-free shell and plans to then seek a merger opportunity. The company will seek to sell its Richmond real estate and its Mimotopes Pty. Ltd. subsidiary. Last year, Commonwealth divested its Fairfax Identity Laboratories and CBI Services divisions to Bostwick Laboratories (Glen Allen, Va.) and also announced that it would acquire peptide supply company GL Biochem (Shanghai) Ltd. (Shanghai, China). Commonwealth has since stated that is "highly unlikely" that the GL Biochem deal will close. ...